Intelligent Bio Solutions

Yahoo Finance • 17 days ago

Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance

The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in the second half of 2026 NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Intelligent B... Full story

Yahoo Finance • 2 months ago

Intelligent Bio Solutions rise on record cartridge sales

* Intelligent Bio Solutions reports record monthly cartridge sales for July. * Shipped 519 boxes, representing around 12500 cartridges, and a 60% year-on-year. * A recent significant tender win has secured a multi-site, high-volume c... Full story

Yahoo Finance • 2 months ago

Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July

NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its highest-... Full story

Yahoo Finance • 2 months ago

Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies

Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue growth of 16%, supported by increas... Full story

Yahoo Finance • 2 months ago

Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025

NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing and screening solutions, today announce... Full story

Yahoo Finance • 2 months ago

Intelligent Bio Solutions expects 16% year over year growth in fourth quarter revenue

* Intelligent Bio Solutions (NASDAQ:INBS [https://seekingalpha.com/symbol/INBS]) announced [https://seekingalpha.com/pr/20193193-intelligent-bio-solutions-announces-preliminary-fiscal-fourth-quarter-revenue-with-double] on Thursday preli... Full story

Yahoo Finance • 2 months ago

Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum

Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry and strengthened global readiness through... Full story

Yahoo Finance • 2 months ago

EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4

Intelligent Bio Solutions Inc. (NASDAQ:INBS) reported preliminary fiscal fourth quarter revenue results and selected operational highlights on Thursday. Intelligent Bio Solutions is a medical technology company delivering intelligent, rap... Full story

Yahoo Finance • 2 months ago

Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch

NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the submissi... Full story

Yahoo Finance • 2 months ago

Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has secur... Full story

Yahoo Finance • 3 months ago

Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience

Data confirms Company’s ability to detect trace sweat volumes at ultra-micro level System demonstrates resilience across diverse conditions NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INB... Full story

Yahoo Finance • 3 months ago

Intelligent Bio Solutions expands global reach with SmarTest Patch

NEW YORK - Intelligent Bio Solutions Inc. (Nasdaq:INBS) announced Wednesday a new global distribution agreement with Texas-based SMARTOX to distribute its SmarTest Patch drug detection product in international markets outside the United St... Full story

Yahoo Finance • 3 months ago

Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a new global... Full story

Yahoo Finance • 3 months ago

Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing

NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition... Full story

Yahoo Finance • 3 months ago

Intelligent Bio Solutions amends executive contracts and raises salaries

Intelligent Bio Solutions Inc. (NASDAQ:INBS), a micro-cap company with a market capitalization of $12.65 million, announced amendments to the employment agreements of its President and Chief Executive Officer, Harry Simeondis, and Chief Fi... Full story

Yahoo Finance • 4 months ago

Intelligent Bio Solutions expands drug screening in Scandinavia

NEW YORK - Intelligent Bio Solutions Inc. (NASDAQ:INBS), a micro-cap healthcare technology company with a market value of $12.3 million, is expanding its fingerprint-based drug screening technology across Scandinavia through its partnershi... Full story

Yahoo Finance • 4 months ago

Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening solutions, today announced the success... Full story

Yahoo Finance • 4 months ago

Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Managed... Full story

Yahoo Finance • 4 months ago

Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing

SMARTOX has deployed over 50 of INBS’ Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone Company continues to actively pursue FDA clearance in connec... Full story

Yahoo Finance • 5 months ago

Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing

INBS to participate with U.S. distribution partner SMARTOX at RISE25, the leading U.S. conference on addiction, mental health, and justice innovation which draws over 7,000 attendees annually With over 450 active accounts across 24 countr... Full story